<p>Brown Advisory Inc. 在最近向證券交易委員會（SEC）提交的 13F 文件中表示，在第二季度減少了對 LifeStance Health Group, Inc. (NASDAQ:LFST - 免費報告) 的持股比例，減少幅度為 10.5%。該機構投資者在此期間出售了 611,977 股後，持有該公司 5,210,638 股股票。Brown Advisory Inc. 在最近的報告期末持有 LifeStance Health Group 約 1.34% 的股份，價值 26,939,000 美元。</p>
<p>其他一些機構投資者也最近對該股票的持倉進行了調整。Jacobs Levy Equity Management Inc. 在第一季度以 7,932,000 美元的估值購買了 LifeStance Health Group 的新頭寸。Adage Capital Partners GP L.L.C. 在第一季度將其在 LifeStance Health Group 的股份增加了 43.8%。Adage Capital Partners GP L.L.C. 目前持有該公司 230,000 股股票，價值 1,532,000 美元，此前在上個季度又購買了 70,000 股。TD Asset Management Inc 在第二季度以約 780,000 美元的估值購買了 LifeStance Health Group 的新頭寸。Nuveen LLC 在第一季度以約 6,928,000 美元的估值購買了 LifeStance Health Group 的新股份。最後，洛杉磯資本管理公司在第二季度以約 219,000 美元的估值購買了 LifeStance Health Group 的新股份。機構投資者持有該公司 85.50% 的股份。</p>
<h2>分析師評級調整</h2>
<p>多位研究分析師對 LFST 股票發表了評論。Zacks Research 在 11 月 5 日的研究報告中將 LifeStance Health Group 的股票評級從 &#34;強力買入&#34; 下調至 &#34;持有&#34;。BMO Capital Markets 於 11 月 13 日的研究報告中開始覆蓋 LifeStance Health Group 的股票，給予 &#34;跑贏大盤&#34; 的評級和 8.00 美元的目標價。BTIG Research 在 11 月 6 日的研究報告中將 LifeStance Health Group 的目標價從 8.00 美元上調至 9.00 美元，並給予該股票 &#34;買入&#34; 的評級。華爾街禪在 10 月 11 日的研究報告中將 LifeStance Health Group 的評級從 &#34;買入&#34; 下調至 &#34;持有&#34;。最後，瑞銀集團在 11 月 7 日的研究報告中將 LifeStance Health Group 的目標價從 9.00 美元上調至 10.00 美元，並給予該公司 &#34;買入&#34; 的評級。一位股票研究分析師給予該股票 &#34;強力買入&#34; 的評級，六位分析師給予 &#34;買入&#34; 的評級，一位分析師給予 &#34;持有&#34; 的評級，一位分析師給予 &#34;賣出&#34; 的評級。根據 MarketBeat.com 的數據，該公司目前的平均評級為 &#34;適度買入&#34;，平均目標價為 9.00 美元。</p>
<p><strong>查看我們對 LFST 的最新股票分析</strong></p>
<h2>LifeStance Health Group 的內部買賣</h2>
<p>在其他消息中，內部人士 Lisa K. Miller 於 11 月 21 日星期五出售了 57,240 股該公司的股票。該股票以平均價格 6.43 美元出售，總交易額為 368,053.20 美元。交易後，內部人士直接持有該公司 261,292 股股票，價值約 1,680,107.56 美元。此次交易使其持股比例減少了 17.97%。該交易已在向證券交易委員會的備案中披露，相關信息可通過此鏈接訪問。公司內部人士持有該公司 3.20% 的股份。</p>
<h2>LifeStance Health Group 的價格表現</h2>
<p>LFST 股票在星期五開盤價為 6.48 美元。該股票的市值為 25.2 億美元，市盈率為 -216.00，貝塔值為 1.13。該公司的 50 日移動平均價格為 5.72 美元，200 日移動平均價格為 5.30 美元。公司當前比率為 1.58，速動比率為 1.58，債務與股本比率為 0.18。LifeStance Health Group, Inc. 的 12 個月低點為 3.74 美元，12 個月高點為 8.30 美元。</p>
<p>LifeStance Health Group (NASDAQ:LFST - 獲取免費報告) 最近於 11 月 5 日發佈了其財報。該公司報告本季度每股收益為 0.02 美元，超出分析師一致預期的 -0.01 美元，超出幅度為 0.03 美元。LifeStance Health Group 的淨利潤率為 -0.67%，股本回報率為 -0.62%。該公司本季度的收入為 3.6381 億美元，而分析師預期為 3.5506 億美元。在去年同期，該公司每股收益為 -0.02 美元。LifeStance Health Group 本季度的收入同比增長 16.3%。整體來看，股票分析師預測 LifeStance Health Group, Inc. 本年度每股收益將為 -0.18 美元。</p>
<h2>關於 LifeStance Health Group</h2>
<p>(免費報告)</p>
<p>LifeStance Health Group, Inc. 通過其子公司在美國提供兒童、青少年、成人和老年人的門診心理健康服務。該公司為患者提供一系列心理健康服務，包括精神評估和治療、心理測試和神經心理測試，以及個人、家庭和團體治療。</p>
<h2>精選文章</h2>
<ul>
<li>我們更看好的五隻股票，而不是 LifeStance Health Group</li>
<li>標普 500 股票對投資者的市場指示是什麼？</li>
<li>Ulta 的股票可能會迎來反彈——20% 的上漲空間？</li>
<li>現在購買的三隻最佳藍籌股</li>
<li>比爾和梅琳達·蓋茨基金會出售 MSFT 股票——投資者應該擔心嗎？</li>
<li>什麼是財報？</li>
<li>MarketBeat 週報 – 12/1 - 12/5</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TEZTVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TEZTVA"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 LifeStance Health Group 嗎？</h2>
<p>在你考慮投資 LifeStance Health Group 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 LifeStance Health Group 並不在名單上。</p>
<p>雖然 LifeStance Health Group 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

LFST

<p>Brown Advisory Inc. 在第二季度減少了對 LifeStance Health Group 的持股比例，減持了 10.5%，共售出 611,977 股。分析師對 LFST 的評級不一，整體共識為適度買入，目標價為 9.00 美元。內部人士 Lisa K. Miller 售出了 57,240 股。LFST 報告第三季度每股收益為 0.02 美元，超出預期，營收同比增長 16.3%</p>

<p>Brown Advisory Inc. lessened its stake in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 10.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,210,638 shares of the company's stock after selling 611,977 shares during the period. Brown Advisory Inc. owned approximately 1.34% of LifeStance Health Group worth $26,939,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>Brown Advisory Inc. 在最近向證券交易委員會（SEC）提交的 13F 文件中表示，在第二季度減少了對 LifeStance Health Group, Inc. (NASDAQ:LFST - 免費報告) 的持股比例，減少幅度為 10.5%。該機構投資者在此期間出售了 611,977 股後，持有該公司 5,210,638 股股票。Brown Advisory Inc. 在最近的報告期末持有 LifeStance Health Group 約 1.34% 的股份，價值 26,939,000 美元。</p>
</div><p>A number of other institutional investors have also recently made changes to their positions in the stock. Jacobs Levy Equity Management Inc. bought a new position in LifeStance Health Group in the first quarter valued at $7,932,000. Adage Capital Partners GP L.L.C. increased its position in shares of LifeStance Health Group by 43.8% during the 1st quarter. Adage Capital Partners GP L.L.C. now owns 230,000 shares of the company's stock valued at $1,532,000 after purchasing an additional 70,000 shares during the last quarter. TD Asset Management Inc purchased a new position in shares of LifeStance Health Group during the 2nd quarter valued at about $780,000. Nuveen LLC bought a new stake in LifeStance Health Group in the 1st quarter worth approximately $6,928,000. Finally, Los Angeles Capital Management LLC purchased a new stake in LifeStance Health Group in the second quarter worth approximately $219,000. Institutional investors own 85.50% of the company's stock.</p>
<div class="lb-trans"><p>其他一些機構投資者也最近對該股票的持倉進行了調整。Jacobs Levy Equity Management Inc. 在第一季度以 7,932,000 美元的估值購買了 LifeStance Health Group 的新頭寸。Adage Capital Partners GP L.L.C. 在第一季度將其在 LifeStance Health Group 的股份增加了 43.8%。Adage Capital Partners GP L.L.C. 目前持有該公司 230,000 股股票，價值 1,532,000 美元，此前在上個季度又購買了 70,000 股。TD Asset Management Inc 在第二季度以約 780,000 美元的估值購買了 LifeStance Health Group 的新頭寸。Nuveen LLC 在第一季度以約 6,928,000 美元的估值購買了 LifeStance Health Group 的新股份。最後，洛杉磯資本管理公司在第二季度以約 219,000 美元的估值購買了 LifeStance Health Group 的新股份。機構投資者持有該公司 85.50% 的股份。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師評級調整</h2>
</div><p>A number of research analysts have commented on LFST shares. Zacks Research cut shares of LifeStance Health Group from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Wednesday, November 5th. BMO Capital Markets began coverage on shares of LifeStance Health Group in a research report on Thursday, November 13th. They issued an &#34;outperform&#34; rating and a $8.00 target price on the stock. BTIG Research boosted their price target on shares of LifeStance Health Group from $8.00 to $9.00 and gave the stock a &#34;buy&#34; rating in a research note on Thursday, November 6th. Wall Street Zen cut LifeStance Health Group from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note on Saturday, October 11th. Finally, UBS Group boosted their target price on LifeStance Health Group from $9.00 to $10.00 and gave the company a &#34;buy&#34; rating in a research note on Friday, November 7th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of &#34;Moderate Buy&#34; and an average price target of $9.00.</p>
<div class="lb-trans"><p>多位研究分析師對 LFST 股票發表了評論。Zacks Research 在 11 月 5 日的研究報告中將 LifeStance Health Group 的股票評級從 &#34;強力買入&#34; 下調至 &#34;持有&#34;。BMO Capital Markets 於 11 月 13 日的研究報告中開始覆蓋 LifeStance Health Group 的股票，給予 &#34;跑贏大盤&#34; 的評級和 8.00 美元的目標價。BTIG Research 在 11 月 6 日的研究報告中將 LifeStance Health Group 的目標價從 8.00 美元上調至 9.00 美元，並給予該股票 &#34;買入&#34; 的評級。華爾街禪在 10 月 11 日的研究報告中將 LifeStance Health Group 的評級從 &#34;買入&#34; 下調至 &#34;持有&#34;。最後，瑞銀集團在 11 月 7 日的研究報告中將 LifeStance Health Group 的目標價從 9.00 美元上調至 10.00 美元，並給予該公司 &#34;買入&#34; 的評級。一位股票研究分析師給予該股票 &#34;強力買入&#34; 的評級，六位分析師給予 &#34;買入&#34; 的評級，一位分析師給予 &#34;持有&#34; 的評級，一位分析師給予 &#34;賣出&#34; 的評級。根據 MarketBeat.com 的數據，該公司目前的平均評級為 &#34;適度買入&#34;，平均目標價為 9.00 美元。</p>
</div><p><strong>Check Out Our Latest Stock Analysis on LFST</strong></p>
<div class="lb-trans"><p><strong>查看我們對 LFST 的最新股票分析</strong></p>
</div><h2>Insider Buying and Selling at LifeStance Health Group</h2>
<div class="lb-trans"><h2>LifeStance Health Group 的內部買賣</h2>
</div><p>In other news, insider Lisa K. Miller sold 57,240 shares of the business's stock in a transaction that occurred on Friday, November 21st. The stock was sold at an average price of $6.43, for a total transaction of $368,053.20. Following the transaction, the insider directly owned 261,292 shares of the company's stock, valued at approximately $1,680,107.56. The trade was a 17.97% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 3.20% of the company's stock.</p>
<div class="lb-trans"><p>在其他消息中，內部人士 Lisa K. Miller 於 11 月 21 日星期五出售了 57,240 股該公司的股票。該股票以平均價格 6.43 美元出售，總交易額為 368,053.20 美元。交易後，內部人士直接持有該公司 261,292 股股票，價值約 1,680,107.56 美元。此次交易使其持股比例減少了 17.97%。該交易已在向證券交易委員會的備案中披露，相關信息可通過此鏈接訪問。公司內部人士持有該公司 3.20% 的股份。</p>
</div><h2>LifeStance Health Group Price Performance</h2>
<div class="lb-trans"><h2>LifeStance Health Group 的價格表現</h2>
</div><p>LFST stock opened at $6.48 on Friday. The stock has a market capitalization of $2.52 billion, a price-to-earnings ratio of -216.00 and a beta of 1.13. The firm's 50-day moving average price is $5.72 and its two-hundred day moving average price is $5.30. The company has a current ratio of 1.58, a quick ratio of 1.58 and a debt-to-equity ratio of 0.18. LifeStance Health Group, Inc. has a 12-month low of $3.74 and a 12-month high of $8.30.</p>
<div class="lb-trans"><p>LFST 股票在星期五開盤價為 6.48 美元。該股票的市值為 25.2 億美元，市盈率為 -216.00，貝塔值為 1.13。該公司的 50 日移動平均價格為 5.72 美元，200 日移動平均價格為 5.30 美元。公司當前比率為 1.58，速動比率為 1.58，債務與股本比率為 0.18。LifeStance Health Group, Inc. 的 12 個月低點為 3.74 美元，12 個月高點為 8.30 美元。</p>
</div><p>LifeStance Health Group (NASDAQ:LFST - Get Free Report) last posted its earnings results on Wednesday, November 5th. The company reported $0.02 earnings per share for the quarter, topping analysts' consensus estimates of ($0.01) by $0.03. LifeStance Health Group had a negative net margin of 0.67% and a negative return on equity of 0.62%. The company had revenue of $363.81 million during the quarter, compared to analyst estimates of $355.06 million. During the same period in the prior year, the business posted ($0.02) earnings per share. LifeStance Health Group's revenue for the quarter was up 16.3% on a year-over-year basis. As a group, equities analysts predict that LifeStance Health Group, Inc. will post -0.18 earnings per share for the current year.</p>
<div class="lb-trans"><p>LifeStance Health Group (NASDAQ:LFST - 獲取免費報告) 最近於 11 月 5 日發佈了其財報。該公司報告本季度每股收益為 0.02 美元，超出分析師一致預期的 -0.01 美元，超出幅度為 0.03 美元。LifeStance Health Group 的淨利潤率為 -0.67%，股本回報率為 -0.62%。該公司本季度的收入為 3.6381 億美元，而分析師預期為 3.5506 億美元。在去年同期，該公司每股收益為 -0.02 美元。LifeStance Health Group 本季度的收入同比增長 16.3%。整體來看，股票分析師預測 LifeStance Health Group, Inc. 本年度每股收益將為 -0.18 美元。</p>
</div><h2>About LifeStance Health Group</h2>
<div class="lb-trans"><h2>關於 LifeStance Health Group</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免費報告)</p>
</div><p>LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.</p>
<div class="lb-trans"><p>LifeStance Health Group, Inc. 通過其子公司在美國提供兒童、青少年、成人和老年人的門診心理健康服務。該公司為患者提供一系列心理健康服務，包括精神評估和治療、心理測試和神經心理測試，以及個人、家庭和團體治療。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than LifeStance Health Group</li>
<li>What Do S&amp;P 500 Stocks Tell Investors About the Market?</li>
<li>Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead?</li>
<li>The 3 Best Blue-Chip Stocks to Buy Now</li>
<li>Gates Foundation Sells MSFT Stock—Should Investors Be Worried?</li>
<li>What Are Earnings Reports?</li>
<li>MarketBeat Week in Review – 12/1 - 12/5</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，而不是 LifeStance Health Group</li>
<li>標普 500 股票對投資者的市場指示是什麼？</li>
<li>Ulta 的股票可能會迎來反彈——20% 的上漲空間？</li>
<li>現在購買的三隻最佳藍籌股</li>
<li>比爾和梅琳達·蓋茨基金會出售 MSFT 股票——投資者應該擔心嗎？</li>
<li>什麼是財報？</li>
<li>MarketBeat 週報 – 12/1 - 12/5</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TEZTVA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=LFST"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in LifeStance Health Group Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 LifeStance Health Group 嗎？</h2>
</div><p>Before you consider LifeStance Health Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮投資 LifeStance Health Group 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LifeStance Health Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 LifeStance Health Group 並不在名單上。</p>
</div><p>While LifeStance Health Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 LifeStance Health Group 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Brown Advisory Inc.出售了 611,977 股 LifeStance Health Group, Inc.的股票，股票代碼為$LFST